BridgeMD
New treatment option for Primary Open Angle Glaucoma
Official title A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
ClinicalTrials.gov ID: NCT06223048
What this study is testing
What is AMDX-2011P?
AMDX-2011P is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for primary open angle glaucoma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 and older
You may be able to join if
- Diagnosis of primary open angle glaucoma in both eyes
- Able to fixate
- Glaucomatous optic nerve damage in both eyes, as determined by an investigator as part of an eye exam
You likely can't join if
- Participants unable to read or write
- Ocular media is not sufficiently clear to obtain acceptable quality images
- Participants with presence of any ocular pathology other than glaucoma in the study eye (cataracts are acceptable)
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Glendale, California, United States
- Newport Beach, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Glendale, California, United States; Newport Beach, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.